PaulYangMDPhD
Ophthalmology • Portland, ORCataract Related, Retinal Disease, Uveitis
Associate Professor, Ophthalmic Genetics & Ocular Immunology
Dr. Yang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
545 SW Campus Dr
Portland, OR 97239Phone+1 503-494-8311
Education & Training
Oregon Health Science University HospitalFellowship, Ophthalmic Genetics and Inherited Retinal Degeneration, 2012 - 2013
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Ocular Immunology/Uveitis, 2011 - 2012
University of Utah HealthFellowship, Surgical Retina and Vitreous, 2010 - 2011- University of Utah HealthResidency, Ophthalmology, 2007 - 2008
- University of Utah HealthInternship, Internal Medicine, 2006 - 2007
Geisel School of Medicine at DartmouthClass of 2006
DartmouthPhD, Neurophysiology , 1998 - 2003
Certifications & Licensure
OR State Medical License 2012 - 2025
MA State Medical License 2011 - 2015
UT State Medical License 2007 - 2014
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Safety and Efficacy of rAAV-hRS1 in Patients With X-linked Retinoschisis (XLRS) Start of enrollment: 2015 May 01
Publications & Presentations
PubMed
- Electroretinography of disease activity and treatment response in birdshot chorioretinopathy.Christopher R Rosenberg, Elizabeth White, Aseel Alsamarraie, Sandip Suresh, Wayne Tschetter
Eye. 2025-03-28 - Gene Therapy-Associated Uveitis (GTAU): Understanding and mitigating the adverse immune response in retinal gene therapy.Ryan Purdy, Molly John, Alissa Bray, Alison J Clare, David A Copland
Progress in Retinal and Eye Research. 2025-03-14 - SUCCESSFUL TREATMENT OF CANCER-ASSOCIATED RETINOPATHY WITH INTRAVITREAL DEXAMETHASONE IMPLANT FOLLOWED BY A 0.18-MG FLUOCINOLONE IMPLANT WITHOUT SYSTEMIC IMMUNOSUPPRES...Lingling Huang, Paul Yang, Christina Flaxel, Eric Suhler, Phoebe Lin
Retinal Cases & Brief Reports. 2025-03-01
Press Mentions
SpliceBio Announces First Patient Dosed in Phase 1/2 ASTRA Study of SB-007, a Dual-AAV Gene Therapy for Stargardt DiseaseMarch 14th, 2025- SpliceBio Announces U.S. FDA IND Clearance of SB-007 to Commence Phase 1/2 Clinical Study in Patients with Stargardt DiseaseDecember 12th, 2024
- Gene Therapy Allows Teen to See Snowflakes for the First TimeApril 5th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
